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Introduction 
Kasa is the debilitating disease of Pranavaha 
strotas, when untreated, it may lead to dreadful diseases 
like Shwasa (Asthma), Shosha (cachexia), Rajyakshama 
(tuberculosis), Urakshata (chest injury) and  Rakttapitta 
(bleeding like haemoptysis) (1).Kasa may develop as an 
independent disease, symptom or  complication  of a 
disease. Kasa is broadly classified as Ardrakasa and 
Shushkakasa. Kaphaja Kasa is a type of Ardra Kasa 
dominated by Kapha and Vatadushti. Vata and Kapha 
are the two key pathological factors involved in the 
Samprapti (etiopathogenesis) of Kaphaja Kasa (2).
Kaphaja Kasa is one of Pranvahastrotodusti 
Janita Vyadhi where Kasavega is associated with 
Bahala Ghana Nishtivana. It can be correlated with 
Chronic Bronchitis due to similarities of signs and 
symptoms. Chronic Bronchitis is characterized by 
cough associated with sputum for at least 3 consecutive 
months for more than 2 successive years. The initial 
symptoms are repeated attacks of productive cough 
which shows a steady increase in severity during the 
winter months and present all the year round with 
recurrent respiratory infections (3).
According to estimates from national interviews 
taken by the national center for health statistics 
approximately 9.5 million people or 4% of the 
population were diagnosed with Chronic Bronchitis. In 
one study acute bronchitis affected 44 of 1000 adults 
annually. Chronic Bronchitis is more prevalent in 
people older than 50 years (4).
According to National center for health 
statistics, 62 million cases of common cold and cough 
occurs each year. Cough is the fifth most common 
symptom for which patients seeks medical care. 
Ayurveda described many herbomineral formulations 
for management of Kasa. One such formulation 
Bibhitakavaleha is mentioned in Gadanigraha (5), 
which consists of Bibhitaki (Terminalia bellerica 
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Kasa is the disease of Pranavaha strotas. It may develop as an independent disease, symptom or 
complication. In Kaphaja Kasa Kasavega is associated with Bahala Ghana Nishtivana. It can be correlated with 
Chronic Bronchitis due to similarities of signs and symptoms. Chronic Bronchitis is characterized by productive 
cough associated with sputum for at least 3 consecutive months for more than two successive years. The initial 
symptoms are repeated attacks of productive cough which shows a steady increase in severity during the winter 
months and present all the year round with recurrent respiratory infections. Ayurveda described many herbomineral 
formulations for management of Kasa. One such formulation Bibhitakavaleha is mentioned in Gadanigraha, which 
consists of Bibhitaki (Terminalia bellerica Roxb.), Gomutra (Cow urine) and Madhu (Honey). Methods: In this case 
series 30 patients having classical symptoms of Kaphaja Kasa were treated with Bibhitakavaleha 10gm twice a day 
with lukewarm water for 15 days with the aim to prove the efficacy of it in the management of Kaphaja Kasa. 
Subjective criteria like Kasavega, Kasa nishtiva, Shwaskricchrata, Peenas, Shirshool and Aruchi with Laboratory 
parameters like TLC (Total Leukocyte Count), Neutrophils, Absolute Eosinophil Count (AEC) and ESR (Erythrocyte 
Sedimentation Rate) were assessed before and after treatment. Result: Significant improvement was observed in all 
parameters after treatment. Bibhitaki possesses Kashaya Rasa, Madhura Vipaka, Ushna Veerya & Laghu, Ruksha 
Guna which plays a major role in relieving Kasa. Conclusion: Hence it can be concluded that Kaphaja Kasa can be 
effectively treated with Bibhitakavaleha.
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Roxb.), Gomutra (Cow urine) and Madhu (Honey). 
Bibhitaki is indicated by Acharya Vagbhata in all types 
of Shwasa & Kasa (6). Bibhitaki possess Kashaya Rasa, 
Madhura Vipaka, Ushna Veerya & Laghu, Ruksha 
Guna (7) which plays a major role in relieving Kasa. 
Need of the study
As Pranavaha Strotas conveys Prana, any 
disease affecting this Strotas has to be treated with 
priority. Kaphaja Kasa may not be life threatening but 
increasingly annoying and irritating to the individual in 
his routine activity. When neglected it may lead to a 
series of complications later. 
In recent years, there has been surprisingly 
increase of incidence related to Respiratory system 
because of the exposure to both active and passive 
smoke, air pollution, occupational hazards (8). No 
research Study on Bibhitakavaleha in management of 
Kaphaj Kasa was conducted yet. Hence a clinical study 
will be planned to prove efficacy of it in management of 
Kaphaja Kasa.
Aims and Objectives
Aim: Study the efficacy of Bibhitakavaleha in Kaphaja 
Kasa
Objectives 
• To assess the efficacy of Bhibhitakavaleha in Kasa 
Vega and Kasa Nishtivana
• To assess the effect of Bibhitakavaleha in 
Shwaskricchrata (Dyspnoea)
• To know the effect of Bibhitakavaleha on Laboratory 
parameters like TLC (Total Leukocyte Count), 
Neutrophils, Absolute Eosinophil Count (AEC) and 
ESR (Erythrocyte Sedimentation Rate) 
Materials and Methods
• Source of study: The Patients were selected from 
Kayachikitsa O.P.D. and I.P.D. of Mahatma Gandhi 
Ayurved College, Hospital & Research Centre, Salod 
(H) and from peripheral camps. 
• Study Design:  Single arm
• Study Type: Interventional study 
• Sample size: 30
Inclusion criteria
• Patients aged between 20 and 70 years of either sex 
• Patients having cardinal features of Chronic 
Bronchitis (Chronic cough, Excessive sputum 
production, Dyspnoea).
• Patients with COPD mild and moderate grade (GOLD 
guidelines).
Exclusion Criteria 
• Known cases of Tuberculosis, Lung cancer, 
Bronchiectasis, Interstitial lung disease, CHD, DM, 
Pneumonia, Pneumothorax.
• Pregnant women and lactating mothers.
Selection of Material
Bibhitakavaleha was procured from Govigyan 
Anusandhan Santhan, Deolapar, Nagpur (MS). 
Table 1: Composition of Material
Safety Profile
Toxicity study of Bibhitaki- Thanabhorn S. et 
al. (2009) conducted acute and sub acute toxicity 
studies as per the OECD guidelines. Single oral 
administration of the ethanolic extract of T. belerica at a 
dose of 5,000 mg/kg did not produce any toxicity. In 
sub acute toxicity, repeated administration of 1,000 mg/
kg of T. belerica over 14 days did not cause changes in 
terms of general behaviors, mortality, weight gain, 
hematological or clinical blood chemistry parameters. 
The results of histological examinations showed normal 
appearance of the internal organs when compared to 
those of the control group (9).  
Toxicity study of Gomutra
In acute toxicity study, no toxicity was observed 
even when cow urine was given 32ml/kg which was 
32times of the study dose, which suggests that cow 
urine is having very high therapeutic index. Although 
no histopathological studies were undertaken, it was 
surmised that Gomutra Arka is safe in animals (10).
Toxicity of honey
A study conducted on mice results suggested 
the harmful side effects of cadmium on liver and 
kidney, and it was concluded that honey via its 
antioxidant activity has the ability to protect against 
cadmium induced hepatotoxicity and nephrotoxicity 
(11). No any toxic effects of honey were noted on liver 
and kidney (12).
Posology
•Dose 10gm two times a day after meal with lukewarm 
water
•Duration - 15 days
•Follow up -During of treatment- After 7th and 15th day.
                  After treatment-30 days
Investigations 
•Total Leukocytes Count 
•Differential count
•Erythrocyte Sedimentation Rate 
•Absolute Eosinophil count 
Assessment Criteria 
•Patients were assessed for subjective and objective 
criteria on 0, 7, 15 day 
Sr.no. N a m e o f 
drug
Latin name Part used
1 Bhibhitaki Terminalia belerica 
Roxb.
Fruit
2 Gomutra Cow Urine Mutra
3 Honey Mel -
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Table 2: Subjective Criteria
Objective criteria
Objective criteria Total Leukocyte Count (TLC), Differential Leukocyte Count (DLC), Erythrocyte 
Sedimentation Rate (ESR) and Absolute Eosinophil Count (AEC) were assessed before and after treatment. 
Observations and Results
Statistical analysis was done by using descriptive and inferential statistics using chisquare test, student’s 
paired t test and Wilcoxon signed rank test and software used in the analysis was SPSS 24.0 version and Graphpad 
Prism 7.0 version and p<0.05 is considered as level of significance.
Age wise distribution of patient showed that maximum patients 13 (43.33%) were in the age group of 51-60 
yrs. In this study number of male patients were more that is 17 (56.67%) as compared to female. Occupation wise 
distribution showed that maximum patients were housewives 11 (36.67%). In this study maximum patients 
14(46.67%) belonged to lower socioeconomic group. In this study family history was present in 16 (53.33%) patients, 
maximum patients 14 (46.67%) had not addicted to any type of habit, 16(53.33%) patients were taking vegetarian diet, 
18(60%) patients had no history of any type of allergy and sleep was disturbed in 16 (53.33%) patients.  In this 
study14 (46.67%) patients had madhyam akruti, jivha was saam in 17(56.67 %) patients, vatakapha prakruti was 
found in 13 (43.33%) patients, 17 (56.67 %) patients had mandagni and 16 (53.33%) patients had madhyam koshtha.
Table 3: Comparison of Kasavega before and after treatment 
Wilcoxon signed rank test
                           
Table 4: Comparison of Kaphanishtivana before and after treatment
Wilcoxon signed rank test
                             
 Table 5: Comparison of Shwasakruchrata before and after treatment
Wilcoxon signed rank test
SN Criteria 0 1 2 3
1 Kasa Vega 
(Bouts of cough)
No coughing Coughing 1 to 3 
times in 24hrs.
Coughing  4 to 6 
times in 24hrs
Coughing more than 6 
times in 24hrs.
2 Kasa Nishtivana 
(Sputum)
No sputum Sputum early in 
the morning
Sputum 2 - 3 times 
daily
Sputum with each 
coughing
3 Shwaskricchrata 
(Breathlessness)
No breathlessness 
except with 
strenuous exercise
Breathlessness 
when hurrying on 
the level or 
walking up a slight 
hill
Stops for breath 
after walking about 
100 m or after a few 
minutes on level 
ground
Too breathless to leave 
the house or breathless 
when dressing or 
undressing
4 Shirshool 
(Headache)
No Shirshool Shirshool  
Occasionally
Shirshool 
Frequently
Continuous Shirshool 
which disturbs day to 
day activities
5 Peenas  
(Cold)
Absent Present - -
6 Agnimandya 
(Loss of appetite)
Absent Present - --
7 Aruchi 
(Tastelessness)
Absent Present - -
Mean N Std. Deviation Std. Error Mean z-value
BT 2.60 30 0.49 0.09 21.52 
P=0.0001, SAT 0.36 30 0.49 0.08
Mean N Std. Deviation Std. Error Mean z-value
BT 2.70 30 0.53 0.09 17.94 
P=0.0001,SAT 0.40 30 0.49 0.09
Mean N Std. Deviation Std. Error Mean z-value
BT 1.46 30 0.62 0.11 12.33
P=0.0001,SAT 0.06 30 0.25 0.04
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Table 6: Comparison of Shirshool before and after treatment
Wilcoxon signed rank test
Table 7: Comparison of Peenas before and after treatment
Table 8: Comparison of Agnimandya before and after treatment
                                          Table 9: Comparison of Aruchi before and after treatment
Table 10: Comparison of Hb% before and after treatment
Student’s paired t test
Table 11: Comparison of TLC before and after treatment
Student’s paired t test
Table 12: Comparison of Neutrophil before and after treatment
Student’s paired t test
 Table 13: Comparison of Eosinophils before and after treatment
Wilcoxon Signed Rank test
Table 14: Comparison of AEC before and after treatment
Student’s paired t test
Table 15: Comparison of ESR before and after treatment
Student’s paired t test
Mean N Std. Deviation Std. Error Mean z-value
BT 1.20 30 0.84 0.15 7.30 
P=0.0001,SAT 0.03 30 0.18 0.03
Peenas BT AT Χ2-value
Present 23(76.67%) 0(0%) 49.09 
P=0.0001,SAbsent 7(23.33%) 30(100%)
Total 30(100%) 100(100%)
Agnimandya BT AT Χ2-value
Present 15(50%) 0(0%) 20.00 
P=0.0001,SAbsent 15(50%) 30(100%)Total 30(100%) 100(100%)
Aruchi BT AT Χ2-value
Present 15(50%) 0(0%) 20.00 
P=0.0001,SAbsent 15(50%) 30(100%)Total 30(100%) 100(100%)
Mean N Std. Deviation Std. Error Mean t-value
BT 12.85 30 1.40 0.25 3.49 
P=0.002,SAT 13.13 30 1.23 0.22
Mean N Std. Deviation Std. Error Mean t-value
BT 8523.33 30 2464.04 449.87 2.74 
P=0.010,SAT 7710.00 30 1684.48 307.54
Mean N Std. Deviation Std. Error Mean t-value
BT 65.15 30 8.50 1.55 2.72 
P=0.011,SAT 61.80 30 6.30 1.15
Mean N Std. Deviation Std. Error Mean z-value
BT 2.40 30 1.03 0.18 3.45 
P=0.002,SAT 1.83 30 0.53 0.09
Mean N Std. Deviation Std. Error Mean t-value
BT 196.63 30 81.34 14.85 4.16 
P=0.0001,SAT 138.40 30 45.90 8.38
Mean N Std. Deviation Std. Error Mean t-value
BT 46.00 30 22.14 4.04 8.18 
P=0.0001,SAT 28.30 30 12.65 2.30
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Mean of Kasavega before treatment was 2.60 
which reduced to 0.36 after treatment. Significant 
improvement was observed in Kasavega after treatment 
with significant p value (21.52, P=0.0001). Mean of 
Kaphanishtivana before treatment was 2.70 which 
reduced to 0.40 after treatment. Significant 
improvement was observed in Kaphanishtivana after 
treatment with significant P value (17.94, P=0.0001). 
Mean of Shwasakruchrata before treatment was 1.46 
which reduced to 0.06 after treatment. Significant 
improvement was observed in Shwasakruchrata after 
treatment with significant P value (12.33, P=0.0001). 
Mean of Shirshool before treatment was 1.20 which 
reduced to 0.03 after treatment. Significant 
improvement was observed in Shirshool after treatment 
with significant P value (7.30, P=0.0001). Peenas was 
present in 23(76.67%) patients before treatment but 
after treatment it was absent in all. Complete 
improvement was observed in Peenas with significant P 
value (49.09, P=0.0001). Agnimandya was present in 
15(50%) patients before treatment but after treatment it 
was absent in all. Complete improvement was observed 
in Agnimandya with significant P value (20.00, 
P=0.0001). Aruchi was present in 15(50%) patients 
before treatment but after treatment it was absent in all. 
Complete improvement was observed in Aruchi with 
significant P value (20.00, P=0.0001).
Mean of Hb% before treatment was 12.85% 
which increased to 13.13% after treatment. Significant 
improvement was observed in Shirshool after treatment 
with significant P value (3.49, P=0.002). Mean of TLC 
before treatment was 8523.33 which decreased to 
7710.00 after treatment. Significant improvement was 
observed in TLC after treatment with significant P value 
(2.74, P=0.010). Mean of Neutrophil before treatment 
was 65.15 which decreased to 61.80 after treatment. 
Significant improvement was observed in Neutrophil 
after treatment with significant P value (2.72, P=0.011). 
Mean of Eosinophils before treatment was 2.40 which 
decreased to 1.83 after treatment. Significant 
improvement was observed in Eosinophils after 
treatment with significant P value (3.45, P=0.002). 
Mean of AEC before treatment was 196.63 which 
decreased to 138.40 after treatment. Significant 
improvement was observed in AEC after treatment with 
significant P value (4.16, P=0.0001). Mean of ESR 
before treatment was 46.00 which decreased to 28.30 
after treatment. Significant improvement was observed 
in ESR after treatment with significant P value (8.18, 
P=0.0001).
Discussion 
Kasa is a vyadhi of pranavaha strotas and 
Kaphaja Kasa is a type of Ardra Kasa in which there is 
Kapha and Vatadushti. In this study Bibhitakavaleha 
was used in Kaphaja kasa which is mentioned in 
Gadanigraha (13). 
In this study total 30 patients having classical 
symptoms of Kaphaja Kasa were treated with 
Bibhitakavaleha, 10gm twice a day with lukewarm 
water for 15 days. Patients were assessed for subjective 
as well as objective criteria before and after completion 
of treatment. Patients were assessed for subjective 
c r i t e r i a l i k e K a s a v e g a , K a p h a n i s h t i v a n a , 
Shwaskruchrata, Shirshool, Peenas, Agnimandya and 
Aruchi. Objective criteria were Hb%, Total Leucocyte 
Count, Neutrophils, Eosinophils, Absolute Eosinophil 
count and Erythrocyte Sedimentation Rate.
In this study significant improvement was 
observed in all subjective as well as objective 
parameters after completion of treatment. Ingredients of 
Bibhitakavaleha are Bibhitaki (Terminalia bellerica 
Roxb.), Gomutra and Madhu. Acharya Charak included 
Bibhitaki in Kasahar and jwarhar dravyas (14).
 Bibhitaki is indicated by Acharya Vagbhata in 
all types of Shwasa & Kasa. Bibhitaki is Kashaya Rasa, 
Madhura Vipaka, Ushna Veerya & Laghu, Ruksha Guna 
which plays a major role in relieving Kasa. It has 
kaphavata shamak property which helps in pacification 
thereby balancing doshas. Mruduvirechaka property of 
Bibhitaki helps in vatanulomana and normalizes gati of 
vata (15). It possesses Rasayana property which 
helps in boosting immune system (16). 
Ayurvedic texts classify Bibhitaki under the 
group of herbs that are useful in treating cold, cough 
and fever (17). It is said to be having a balancing 
effect on Kapha and Pitta. Gomutra possesses 
antimicrobial and immune-modulatory property that 
helps in reducing symptoms of Kaphaja kasa (18).  
Madhu (honey) helps in reducing Kasavega 
and Kaphanishtivana.  Honey has antimicrobial, 
antioxidant and anti-inflammatory properties. Research 
study reported that in temperate climates and places 
with considerable temperature fluctuations, honey is a 
well-known remedy for colds and mouth, throat or 
bronchial irritations and infections (19). There is 
increasing evidence that a single dose of honey might 
reduce mucus secretion and reduce cough in children. In 
a research study conducted on healthy men, honey 
showed good demulcent effect and antioxidant 
properties, and increased cytokine release, which might 
be due to its antimicrobial effects (20). 
 In this study 30 patients of Kaphaja kasa were 
treated with Bibhitakavaleha. It gave a significant 
improvement in all subjective parameters. Objective 
parameters like Hb%, TLC, DLC, AEC and ESR have 
no much significant role in assessment of cough. So to 
evaluate the efficacy of Bibhitakavaleha, more specific 
objective parameters like Lung Function Test should be 
taken and further study should be conducted on large 
sample size. To prove efficacy of Bibhitakavaleha a 
comparative study should be conducted by taking 
standard drug as a control group with blinding.
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Conclusion 
Kaphaj kasa can be managed effectively by 
herbal formulation Bibhitakavaleha mentioned in 
Gadanigraha.
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